Skip to main content
Erschienen in: Current Geriatrics Reports 1/2018

26.01.2018 | Neurology of Aging (K. Marder, Section Editor)

Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia

verfasst von: James E. Galvin

Erschienen in: Current Geriatrics Reports | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Dementia detection in the community is challenging. The purpose of this paper is to review methods of dementia screening and provide a useable algorithm for screening for dementia a variety of clinical settings.

Recent Findings

In recent years, a number of brief performance and informant-based assessments have been developed and validated in research, clinical, and community samples. These assessments are now complemented by patient self-reports that afford the ability to detect subjective cognitive impairment.

Summary

An optimal approach to dementia screening is to combine performance, informant, and self-reports, many of which can be completed in the waiting room or by non-physician staff prior to the start of the office visit. This diverse information may help inform the provider as to the presence or absence of a cognitive disorder, assist in staging the extent of the disorder, and help to develop a differential diagnosis and management plan.
Literatur
1.
Zurück zum Zitat • Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement. 2016;12:459–509. An annually updated paper covering all aspects of Alzheimer’s disease.CrossRef • Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement. 2016;12:459–509. An annually updated paper covering all aspects of Alzheimer’s disease.CrossRef
2.
Zurück zum Zitat • Haaksma ML, Vilela LR, Marengoni A, Calderón-Larrañaga A, Leoutsakos JS, Olde Rikkert MGM, et al. Comorbidity and progression of late onset Alzheimer’s disease: a systematic review. PLoS One. 2017;12:e0177044. A well-done paper discussing the role that multiple comorbidities may plan in onset and progression of Alzheimer’s disease.CrossRefPubMedPubMedCentral • Haaksma ML, Vilela LR, Marengoni A, Calderón-Larrañaga A, Leoutsakos JS, Olde Rikkert MGM, et al. Comorbidity and progression of late onset Alzheimer’s disease: a systematic review. PLoS One. 2017;12:e0177044. A well-done paper discussing the role that multiple comorbidities may plan in onset and progression of Alzheimer’s disease.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Tariq SH, Tumosa N, Chibnall JT, Perry MH III, Morley JE. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder—a pilot study. Am J Geriatr Psychiatry. 2006;14:900–10.CrossRefPubMed Tariq SH, Tumosa N, Chibnall JT, Perry MH III, Morley JE. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder—a pilot study. Am J Geriatr Psychiatry. 2006;14:900–10.CrossRefPubMed
20.
Zurück zum Zitat • Galvin JE. The quick dementia rating system (QDRS): a rapid dementia staging tool. Alzheimers Dement (Amst). 2015;1:249–59. A new instrument that permits the rapid staging of cognitive impairment with high correlation to gold standard measurements such as the Clinical Dementia Rating and neuropsychological testing. • Galvin JE. The quick dementia rating system (QDRS): a rapid dementia staging tool. Alzheimers Dement (Amst). 2015;1:249–59. A new instrument that permits the rapid staging of cognitive impairment with high correlation to gold standard measurements such as the Clinical Dementia Rating and neuropsychological testing.
21.
Zurück zum Zitat • Berman SE, Koscik RL, Clark LR, Mueller KD, Bluder L, Galvin JE, et al. Use of the quick dementia rating system (QDRS) as an initial screening measure in a longitudinal cohort at risk for Alzheimer’s disease. JAD Rep. 2017;1:9–13. A demonstration of the QDRS in a community-based longitudinal Alzheimer Prevention study.PubMedPubMedCentral • Berman SE, Koscik RL, Clark LR, Mueller KD, Bluder L, Galvin JE, et al. Use of the quick dementia rating system (QDRS) as an initial screening measure in a longitudinal cohort at risk for Alzheimer’s disease. JAD Rep. 2017;1:9–13. A demonstration of the QDRS in a community-based longitudinal Alzheimer Prevention study.PubMedPubMedCentral
23.
Zurück zum Zitat • Li C, Neugroschl J, Luo X, Zhu C, Aisen P, Ferris S, et al. The utility of the cognitive function instrument (CFI) to detect cognitive decline in non-demented older adults. J Alzheimers Dis. 2017;60:427–37. The CFI is a useful tool to quantify subjective memory complaints and predict whether patient is likely to go to develop cognitive impairment and dementia.CrossRefPubMed • Li C, Neugroschl J, Luo X, Zhu C, Aisen P, Ferris S, et al. The utility of the cognitive function instrument (CFI) to detect cognitive decline in non-demented older adults. J Alzheimers Dis. 2017;60:427–37. The CFI is a useful tool to quantify subjective memory complaints and predict whether patient is likely to go to develop cognitive impairment and dementia.CrossRefPubMed
24.
Zurück zum Zitat • Rattanabannakit C, Risacher SL, Gao S, Lane KA, Brown SA, McDonald BC, et al. The Cognitive Change Index as a measure of self and informant perception of cognitive decline: relation to neuropsychological tests. J Alzheimers Dis. 2016;51:1145–55. Another recently developed instrument, the CCI helps to quantify subjective memory complaints and predict whether patient is likely to go to develop cognitive impairment and dementia.CrossRefPubMedPubMedCentral • Rattanabannakit C, Risacher SL, Gao S, Lane KA, Brown SA, McDonald BC, et al. The Cognitive Change Index as a measure of self and informant perception of cognitive decline: relation to neuropsychological tests. J Alzheimers Dis. 2016;51:1145–55. Another recently developed instrument, the CCI helps to quantify subjective memory complaints and predict whether patient is likely to go to develop cognitive impairment and dementia.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1983;17:37–49.CrossRef Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1983;17:37–49.CrossRef
27.
Zurück zum Zitat • Vogel JW, Varga Doležalová M, La Joie R, Marks SM, Schwimmer HD, Landau SM, et al. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly. Neurology. 2017;89:2002–9. A recent study examining the relationship between subjective cognitive decline and amyloid burden, but is limited by the capture of data extracted from the Geriatric Depression Scale.CrossRefPubMed • Vogel JW, Varga Doležalová M, La Joie R, Marks SM, Schwimmer HD, Landau SM, et al. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly. Neurology. 2017;89:2002–9. A recent study examining the relationship between subjective cognitive decline and amyloid burden, but is limited by the capture of data extracted from the Geriatric Depression Scale.CrossRefPubMed
Metadaten
Titel
Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia
verfasst von
James E. Galvin
Publikationsdatum
26.01.2018
Verlag
Springer US
Erschienen in
Current Geriatrics Reports / Ausgabe 1/2018
Elektronische ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-018-0236-2

Weitere Artikel der Ausgabe 1/2018

Current Geriatrics Reports 1/2018 Zur Ausgabe

Physical Therapy and Rehabilitation (O. Addison, Section Editor)

Rehabilitation for Individuals with Dementia: Facilitating Success

Physical Therapy and Rehabilitation (O. Addison, Section Editor)

Aging and the Pelvic Floor

Physical Therapy and Rehabilitation (O Addison, Section Editor)

Best Practice for Home Physical Therapy for Older Adults with Heart Failure

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.